Report Categories
View AllRecent Articles
View All
Orla ORLA Q4 earnings beat estimates by 95 but shares drop 2 as investors await clear growth roadmap
State Street Technology Select Sector SPDR ETF XLK Outperformance Amid Broad Tech Rally and Niche Component Volatility
RXRX Recursion Pharmaceuticals posts narrowerthanexpected Q1 2026 loss shares climb 178 on positive investor sentiment
Curiosity CURI Stock Is It Building a Base Technical Weakness 20260427
ServiceNow Stock Gains Favor on Wall Street as Agentic AI Emerges as a Key Growth Driver
PTHS Q1 2026 Earnings Pelthos Therapeutics Surprises with NarrowerThanExpected Loss in Q1 2026
VISN Q1 2026 Earnings Earnings Surge Past Estimates with 7094 EPS Beat
Salesforce Downgraded to Underperform by Bank of America on AI Monetization Worries
CXAI Q4 2025 Earnings EPS Miss Yet Shares Surge 12 on Strategic Progress
QVCGP Q3 2025 Earnings Preferred Stock Reports Significant Loss Amid Ongoing Operational Challenges